(Q61921354)
Statements
A Double Blind, Placebo Controlled, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-00915275 After Oral Administration To Subjects With Type 2 Diabetes Mellitus For 4-Weeks (English)
0 references
February 2007
0 references
40
0 references
18 year
0 references
70 year
0 references